SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-054014
Filing Date
2024-04-29
Accepted
2024-04-29 16:07:24
Documents
4
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242861-2_def14a.htm DEF 14A 470265
2 GRAPHIC sg_davidplusi-bw.jpg GRAPHIC 6675
3 GRAPHIC px_24acurxproxy01pg01-bw.jpg GRAPHIC 201727
4 GRAPHIC px_24acurxproxy01pg02-bw.jpg GRAPHIC 211618
  Complete submission text file 0001104659-24-054014.txt   989270
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40536 | Film No.: 24890668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)